Development of a consumer information leaflet for a prototype over-the-counter mifepristone and misoprostol medication abortion product

Read full text
Authors: Katherine Ehrenreich, M. Antonia Biggs, Shelly Kaller, Lauren J. Ralph, Kelly N. Blanchard, Claudie Kiti Bustamante, Maricela Cervantes, D S Hauser, Emma Hernández, Nathalie Kapp, Tammi Kromenaker, G. Moayedi
+4 more Jamila B. Perritt, Elizabeth G. Raymond, Kari L. White, Daniel Grossman
Cited by: 0
References: 3

Abstract

OBJECTIVES: To develop a well-understood consumer information leaflet for a prototype over-the-counter mifepristone-misoprostol medication abortion product. STUDY DESIGN: From July 2022 to February 2024, we recruited a general population of English-speaking reproductive-age females to review a leaflet during cognitive video interviews. We revised the leaflet iteratively throughout the interviews until reaching saturation in participant feedback. RESULTS: Sixty-three people aged 13 to 49 completed interviews and found the consumer information leaflet to be easy to understand, suggesting minor improvements. CONCLUSIONS: Information related to the use of medication abortion, formatted as a consumer information leaflet for an over-the-counter product, is well understood by potential users.

Fields of Study & Subjects

Reproductive Health and Contraception Pharmacovigilance and Adverse Drug Reactions Pharmaceutical Quality and Counterfeiting

Publication details

Journal / source
Contraception
Volume
156
Pages
111361–111361
Publication date
2 January 2026
Language
EN